Takaaki Masuda

Niigata, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications

Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study.

Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study.

Journal: Scientific reports
Published: January 04, 2026

Multicenter ex vivo evaluation of an α-mannosidase-targeted fluorescent probe for intraoperative margin assessment in breast cancer.

Multicenter ex vivo evaluation of an α-mannosidase-targeted fluorescent probe for intraoperative margin assessment in breast cancer.

Journal: Scientific reports
Published: December 30, 2025

Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance.

Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance.

Journal: Thoracic cancer
Published: December 27, 2025

Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.

Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.

Journal: Cancer immunology, immunotherapy : CII
Published: November 24, 2025

TONSL Promotes Hepatocellular Carcinoma Progression by Inhibiting Apoptosis Through Homologous Recombination Repair.

TONSL Promotes Hepatocellular Carcinoma Progression by Inhibiting Apoptosis Through Homologous Recombination Repair.

Journal: Cancer science
Published: November 11, 2025

Genomic and transcriptomic landscape of carcinogenesis in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS).

Genomic and transcriptomic landscape of carcinogenesis in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS).

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 31, 2025

NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.

NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.

Journal: Cancer science
Published: October 26, 2025

Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinoma.

Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinoma.

Journal: Journal of gastroenterology
Published: June 19, 2025

PSMD12 Overexpression Promotes Lung Adenocarcinoma Progression via Ubiquitin-Proteasome Pathway Dysregulation.

PSMD12 Overexpression Promotes Lung Adenocarcinoma Progression via Ubiquitin-Proteasome Pathway Dysregulation.

Journal: Cancer science
Published: June 11, 2025

ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation.

ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation.

Journal: Cancer science
Published: May 29, 2025

Case Report: Perioperative Management of a Patient with Glycogen Storage Disease Type IXd.

Case Report: Perioperative Management of a Patient with Glycogen Storage Disease Type IXd.

Journal: Surgical case reports
Published: April 24, 2025

Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.

Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology
Published: April 03, 2025
Showing 1-12 of 104

Last Updated: 09/26/2026